Halozyme Therapeutics Inc (HALO)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$61.00

Buy

$65.00

arrow-up$0.31 (+0.50%)

Prices updated at 13 Dec 2025, 00:40 EST

Prices minimum 15 mins delay

Prices in USD

Halozyme Therapeutics Inc is a biotechnology company. It is engaged in research on human enzymes that alter the extracellular matrix and tumor environment.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	829m	1,015m
	637m	856m
	338m	551m
	40.71	54.32
	282m	444m
	452m	657m
Sales, General and administrative	149m	154m
Interest expenses	19m	18m
Provision for income taxes	67m	113m
Operating expenses	299m	304m
Income before taxes	348m	557m
Net income available to common shareholders	282m	444m
	2.13	3.5
Net interest income	-19m	-18m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	2.1	3.43
Free cash flow per share	2.5951	3.0228
Book value/share	1.9656	3.6764
Debt equity ratio	17.88908	4.138843

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	746m	1,085m
Current liabilities	112m	139m
Total capital	1,583m	1,870m
Total debt	1,499m	1,506m
Total equity	84m	364m
Total non current liabilities	-	-
Loans	1,499m	1,506m
Total assets	1,733m	2,063m
Total liabilities	-	-
Cash and cash equivalents	118m	116m
Common stock	127m	123m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	235m	118m
Cash dividends paid	-	-
	373m	468m
Investments (gains) losses	-97m	-263m
	118m	116m
Net income	-	-
	389m	479m
	-15m	-11m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.